Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-analysis of randomized controlled trials

American Journal of Kidney Diseases

Volumn 59, Issue 6, 2012, Pages 810-818

  Wu, Mei Yi ^a   Hsu, Yung Ho ^a   Bai, Chyi Huey ^b   Lin, Yuh Feng ^a   Wu, Chih Hsiung ^a   Tam, Ka Wai ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

anticoagulation; Citrate; continuous renal replacement therapy; heparin; meta analysis

Indexed keywords

CITRIC ACID; HEPARIN;

ARTICLE; BLEEDING; BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HUMAN; HYPOCALCEMIA; INTENSIVE CARE UNIT; KIDNEY INJURY; META ANALYSIS; METABOLIC ALKALOSIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRATES; CRITICAL ILLNESS; FEMALE; HEMORRHAGE; HEPARIN; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME;

EID: 84858793574     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.11.030     Document Type: Article

References (37)

1. C. Ronco Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient Nat Clin Pract Nephrol 3 3 2007 118 119
2. J.H. Reeves, A.R. Cumming, L. Gallagher, J.L. O'Brien, J.D. Santamaria A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration Crit Care Med 27 10 1999 2224 2228
3. P.H. van der Voort, R.T. Gerritsen, M.A. Kuiper, P.H. Egbers, W.P. Kingma, E.C. Boerma Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation Blood Purif 23 3 2005 175 180
4. S. Morabito, I. Guzzo, A. Solazzo, L. Muzi, R. Luciani, A. Pierucci Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding J Nephrol 16 4 2003 566 571
5. G. Biancofiore, M. Esposito, L. Bindi Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients Minerva Anestesiol 69 6 2003 527 534
6. I. Stefanidis, J. Hagel, N. Maurin Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration Contrib Nephrol 116 1995 145 149
7. J.A. Carr, N. Silverman The heparin-protamine interaction A review J Cardiovasc Surg (Torino) 40 5 1999 659 666
8. O. Samuelsson, J. Amiral, P.O. Attman Heparin-induced thrombocytopenia during continuous haemofiltration Nephrol Dial Transplant 10 9 1995 1768 1771
9. R.L. Mehta, B.R. McDonald, M.M. Aguilar, D.M. Ward Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients Kidney Int 38 5 1990 976 981
10. H.M. Oudemans-van Straaten Citrate anticoagulation for continuous renal replacement therapy in the critically ill Blood Purif 29 2 2010 191 196
11. H.M. Oudemans-van Straaten, J.P. Wester, A.C. de Pont, M.R. Schetz Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 32 2 2006 188 202
12. J.S. Park, G.H. Kim, C.M. Kang, C.H. Lee Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration Korean J Intern Med 26 1 2011 68 75
13. D.J. Kutsogiannis, R.T. Gibney, D. Stollery, J. Gao Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Kidney Int 67 6 2005 2361 2367
14. M. Monchi, D. Berghmans, D. Ledoux, J.L. Canivet, B. Dubois, P. Damas Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study Intensive Care Med 30 2 2004 260 265
15. A.R. Jadad, R.A. Moore, D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
16. A. Liberati, D.G. Altman, J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol 62 10 2009 e1 e34
17. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement QUOROM Group Br J Surg 87 11 2000 1448 1454
18. S.P. Hozo, B. Djulbegovic, I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
19. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
20. G.R. Hetzel, M. Schmitz, H. Wissing Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial Nephrol Dial Transplant 26 1 2011 232 239
21. H.M. Oudemans-van Straaten, R.J. Bosman, M. Koopmans Citrate anticoagulation for continuous venovenous hemofiltration Crit Care Med 37 2 2009 545 552
22. N. Fealy, I. Baldwin, M. Johnstone, M. Egi, R. Bellomo A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration Int J Artif Organs 30 4 2007 301 307
23. M.G. Betjes, D. van Oosterom, M. van Agteren, J. van de Wetering Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding J Nephrol 20 5 2007 602 608
24. L. Gabutti, C. Marone, G. Colucci, F. Duchini, C. Schonholzer Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge Intensive Care Med 28 10 2002 1419 1425
25. P.Y. Martin, J.C. Chevrolet, P. Suter, H. Favre Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study Am J Kidney Dis 24 5 1994 806 812
26. A.K. Verma, M. Levine, S.J. Shalansky, C.J. Carter, J.G. Kelton Frequency of heparin-induced thrombocytopenia in critical care patients Pharmacotherapy 23 6 2003 745 753
27. T.E. Warkentin Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia Arch Pathol Lab Med 126 11 2002 1415 1423
28. F. Mariano, D. Bergamo, E.N. Gangemi, Z. Hollo, M. Stella, G. Triolo Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits Int J Nephrol 2011 2011 748320
29. A.J. Tolwani, K.M. Wille Anticoagulation for continuous renal replacement therapy Semin Dial 22 2 2009 141 145
30. R.V. Pinnick, T.B. Wiegmann, D.A. Diederich Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding N Engl J Med 308 5 1983 258 261
31. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure [published online ahead of print May 23, 2011]. J Nephrol. doi:10.5301/JN.2011. 8363.
32. S. Morgera Regional anticoagulation with citrate: expanding its indications Crit Care Med 39 2 2011 399 400
33. S. Morgera, C. Scholle, G. Voss Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience Nephron Clin Pract 97 4 2004 c131 c136
34. M. Joannidis, J. Kountchev, M. Rauchenzauner Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study Intensive Care Med 33 9 2007 1571 1579
35. A.C. de Pont, H.M. Oudemans-van Straaten, K.J. Roozendaal, D.F. Zandstra Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study Crit Care Med 28 2 2000 421 425
36. R.F. Jeffrey, A.A. Khan, J.T. Douglas, E.J. Will, A.M. Davison Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit Artif Organs 17 8 1993 717 720
37. S.M. Bagshaw, K.B. Laupland, P.J. Boiteau, T. Godinez-Luna Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system J Crit Care 20 2 2005 155 161